4272 — Nippon Kayaku Co Share News
0.000.00%
Last trade - 00:00- ¥278bn
- ¥275bn
- ¥242bn
2018 6-month group forecast
Brief: Nippon Kayaku to merge with units
Table: Nippon Kayaku -Q1 group results
Brief: R&I affirms Nippon Kayaku's rating at "A" and says stable outlook-R&I
Table: Nippon Kayaku -2017/18 parent results
Table: Nippon Kayaku -2017/18 group results
Brief: Chugai Pharmaceutical says waiver of claims in patent infringement lawsuit
Brief: Nippon Kayaku initiates phase II clinical trials on NK105 for treatment of breast cancer
Table: Nippon Kayaku - 9-MTH group results
Brief: Nippon Kayaku unit acquires 100 pct stake in RaySpec
Table: Nippon Kayaku -2017/18 group forecast
Table: Nippon Kayaku - 6-MTH group results
Brief: Chugai Pharmaceutical says lawsuit on patent infringement concerning Herceptin injection and petition for provisional disposition order
Table: Nippon Kayaku -Q1 group results
Table: Nippon Kayaku -2016/17 parent results
Table: Nippon Kayaku -2016/17 group results
Table: Nippon Kayaku -9-MTH group results
Table: Nippon Kayaku -2016/17 group forecast
Table: Nippon Kayaku -6-MTH group results